Key Takeaways Johnson & Johnson shares advanced Tuesday after the pharmaceutical and medical device company posted better ...
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...
“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...
The innovative medicine and medtech segments showed solid sales growth. Johnson & Johnson reported a strong increase in sales, but earnings fell due to one-time charges. In the wake of last year's ...
Naturally, much of the near 10-minute discussion was focused on the defense and its struggles. Just one year after leading ...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
It was a relatively quiet day for Pittsburgh Pirates No. 3 prospect Termarr Johnson in his return to the lineup in the ...
Johnson, 52, posted three clips showing how his “Face The Nation” answers on topics including hurricane relief and election ...
David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
Louisville (Ky.) Sacred Heart guard ZaKiyah Johnson, a five-star prospect in the 2025 cycle, is set to take her final ...